| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,270,300 | 2,157,800 | 2,188,600 | 2,279,200 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 2,157,800 | 2,188,600 | 2,279,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 254,300 | 1,833,500 | 2,058,500 | 2,339,700 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 121,900 | 324,300 | 130,100 | (60,500) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (126,400) |
-
|
-
| | Earnings Before Interest And Taxes | 248,300 | 197,900 | 130,100 | (60,500) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 248,300 | 197,900 | 130,100 | (60,500) | | Income Tax Expense | 44,100 | 33,900 | 7,500 | (61,300) | | Minority Interest | (11,300) | (7,000) |
-
|
-
| | | | Net Income From Continuing Ops | 211,200 | 157,000 | 122,600 | 800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 192,900 | 157,000 | 122,600 | 800 | | Preferred Stock And Other Adjustments | (8,200) | (6,700) | (9,800) | (8,300) | | | Net Income Applicable To Common Shares | $184,700 | $150,300 | $112,800 | ($7,500) |
|
1.29% Nasdaq 
Income Statement
